Latest News & Developments
pharmaceutical
BRICS+ Series: Nigeria-India Economic Relationship
The Nigeria-India partnership represents a new model of South-South cooperation that transcends traditional aid relationships. Focusing on strategic collaboration in pharmaceuticals, energy sector development, and knowledge exchange, this relationship demonstrates how emerging economies are reshaping global power dynamics while addressing shared development challenges. As both nations engage more actively in platforms like BRICS, their partnership offers insights into the future of international economic relations.
BRICS+ Series: How Egypt is Revolutionising Africa's Pharmaceutical Industry
Egypt is transforming into Africa's pharmaceutical powerhouse, with 90% of drugs now produced locally. Through strategic BRICS partnerships, billion-dollar investments, and cutting-edge technology, Egypt is revolutionising healthcare access across Africa while building a $3 billion export industry by 2030. From vaccine manufacturing to Egyptian medical tourism, Cairo's ambitious vision is reshaping the continent's healthcare landscape.
South African Competition Commission probes Novo Nordisk and Sanofi over insulin pen market
South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over their insulin pen market practices, amid growing concerns about accessibility and pricing.
Drug recall of the antidepressant Cymbalta
Cymbalta faces a recall as the FDA detects harmful levels of N-nitroso-duloxetine, a chemical linked to cancer.
Aspen to grow in China and Europe via two interdependent deals
Aspen Pharmacare Holdings has concluded agreements to acquire Sandoz (China) Pharmaceutical and its portfolio of products for up to €92. 6 million (R1. 89 billion), and to dispose of four anaesthetic products on sale in Europe.
University of Limpopo distances itself from ‘bogus’ pharmacist Nthabiseng Ramokolo
It seems social media supersleuths have been busy, this after another ‘bogus’ medical practitioner has been outed.
Aspen Pharmacare gets Viagra as it acquires new brands to broaden its Latin America market
Aspen said its subsidiary, Aspen Global Incorporated (AGI), had concluded the agreement on July 31, 2023. The fair value of the products had been determined by AGI as $280 million (R5. 08 billion).
Totsiens Dis-Chem: Steve Hofmeyr says he won’t shop at the pharmacy again
Controversial Afrikaans singer,Steve Hofmeyr, has vowed never to shop at Dis-Chem again.
Dis-Chem CFO admits sales suffered after ‘no-whites’ jobs moratorium
Dis-Chem says it noted a decline in sales at the time that its letter on the hiring of white staff was leaked to the public.
Take the sting out of HIV/Aids by ending the stigma
OPINION: Reducing HIV-related stigma is the new priority to improve the quality of life for all persons with HIV, writes Michael Buitron.
Profiteering from illness a concern
OPINION: ‘Normalisation’ of minting unbridled profits from illness, is one of the reasons why health and social welfare programmes have failed to deliver equitably, writes Shobha Shukla.
Right ePharmacy closes all Gauteng’s ATM pharmacies after riot destruction
All Right ePharmacy’s ATM pharmacies have been permanently closed in Gauteng after three of the four sites were destroyed in riots, the company said on Tuesday.
Global pharma shares slide as Biden backs COVID-19 vaccine IP waiver
Shares of drugmakers involved in the production of COVID-19 vaccines, including Pfizer and Moderna, fell on Thursday, a day after U. S. President Joe Biden's plan to back intellectual property waivers on vaccines.